Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Griffith, S.
Right arrow Articles by Twycross, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Griffith, S.
Right arrow Articles by Twycross, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Evaluation of the palatability of Oramorph- a proprietary preparation of oral morphine sulphate

S. Griffith

Boehringer Ingelheim, Bracknell

HM Dewberry

Boehringer Ingelheim, Bracknell

JM Titcombe

Boehringer Ingelheim, Bracknell

Pjg McNamara

The Churchill Hospital, Oxford

Jmv Harcourt

The Churchill Hospital, Oxford

RG Twycross

The Churchill Hospital, Oxford

The palatability of Oramorph, a proprietary preparation of morphine sulphate (Boehringer Ingelheim), was compared with an aqueous solution produced by the hospital pharmacy. Thirty patients receiving regular oral morphine sulphate for either pain relief or dyspnoea entered a double-blind, randomized, comparator- controlled crossover trial. Taste preference and other factors were evaluated using Visual Analogue Scales (VAS). Eighteen patients preferred the taste of Oramorph and 12 the hospital formulation. The mean preference in Oramorph's favour, however, did not reach statistical significance (p = 0.3). When each patient's scores were examined separately, 17 expressed a preference, the magnitude of which was of clinical importance, (score of > 30mm on the VAS). Eleven of these were for Oramorph and six for aqueous morphine. When the pleasantness of taste for each solution was assessed independently, a similar result was obtained, with 20 patients rating Oramorph as having a more pleasant taste than aqueous morphine. Ten patients found the reverse to be true. The majority, 22 patients, found Oramorph to be less bitter than aqueous morphine. There was no difference between the smell and texture of the two solutions.

Key Words: morphine • oral administration • taste

Palliative Medicine, Vol. 4, No. 3, 205-209 (1990)
DOI: 10.1177/026921639000400307


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?